2.4.0.8 HtmlAndXml 52 174 1 true 11 0 false 4 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://signpathpharma.com/20130630/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information R1.xml true false R2.htm 000020 - Statement - Balance Sheets Sheet http://signpathpharma.com/20130630/role/idr_BalanceSheets Balance Sheets R2.xml false false R3.htm 000030 - Statement - Balance Sheets Parenthetical Sheet http://signpathpharma.com/20130630/role/idr_BalanceSheetsParenthetical Balance Sheets Parenthetical R3.xml false false R4.htm 000040 - Statement - Statements of Operations Sheet http://signpathpharma.com/20130630/role/idr_StatementsOfOperations Statements of Operations R4.xml false false R5.htm 000050 - Statement - Statements of Cash Flows Sheet http://signpathpharma.com/20130630/role/idr_StatementsOfCashFlows Statements of Cash Flows R5.xml false false R6.htm 000060 - Disclosure - Note 1 - Condensed Financial Statements Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote1CondensedFinancialStatements Note 1 - Condensed Financial Statements R6.xml false false R7.htm 000070 - Disclosure - Note 2 - Going Concern Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote2GoingConcern Note 2 - Going Concern R7.xml false false R8.htm 000080 - Disclosure - Note 3 - Summary of Significant Accounting Policies Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPolicies Note 3 - Summary of Significant Accounting Policies R8.xml false false R9.htm 000090 - Disclosure - Note 4 - Equipment Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote4Equipment Note 4 - Equipment R9.xml false false R10.htm 000100 - Disclosure - Note 5 - Accrued Liabilities Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote5AccruedLiabilities Note 5 - Accrued Liabilities R10.xml false false R11.htm 000110 - Disclosure - Note 6 - Note Payable Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote6NotePayable Note 6 - Note Payable R11.xml false false R12.htm 000120 - Disclosure - Note 7 - Derivative Liability and Fair Value Measurements Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote7DerivativeLiabilityAndFairValueMeasurements Note 7 - Derivative Liability and Fair Value Measurements R12.xml false false R13.htm 000130 - Disclosure - Note 8 - Preferred Stock Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote8PreferredStock Note 8 - Preferred Stock R13.xml false false R14.htm 000140 - Disclosure - Note 9 - Common Stock Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote9CommonStock Note 9 - Common Stock R14.xml false false R15.htm 000150 - Disclosure - Note 10 - Warrants Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote10Warrants Note 10 - Warrants R15.xml false false R16.htm 000160 - Disclosure - Note 11 - Stock Options Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote11StockOptions Note 11 - Stock Options R16.xml false false R17.htm 000170 - Disclosure - Note 12- Subsequent Events Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote12SubsequentEvents Note 12- Subsequent Events R17.xml false false R18.htm 000180 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Use of Estimates (Policies) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesUseOfEstimatesPolicies Note 3 - Summary of Significant Accounting Policies: Use of Estimates (Policies) R18.xml false false R19.htm 000190 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Derivative Financial Instruments (Policies) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesDerivativeFinancialInstrumentsPolicies Note 3 - Summary of Significant Accounting Policies: Derivative Financial Instruments (Policies) R19.xml false false R20.htm 000200 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesFairValueOfFinancialInstrumentsPolicies Note 3 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies) R20.xml false false R21.htm 000210 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Recent Accounting Pronouncements (Policies) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesRecentAccountingPronouncementsPolicies Note 3 - Summary of Significant Accounting Policies: Recent Accounting Pronouncements (Policies) R21.xml false false R22.htm 000220 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Tables) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesScheduleOfDerivativeInstrumentsTables Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Tables) R22.xml false false R23.htm 000230 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Schedule Of Fair Value Of Financial Instruments (Tables) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesScheduleOfFairValueOfFinancialInstrumentsTables Note 3 - Summary of Significant Accounting Policies: Schedule Of Fair Value Of Financial Instruments (Tables) R23.xml false false R24.htm 000240 - Disclosure - Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Tables) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote4EquipmentScheduleOfPropertyAndEquipmentTables Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Tables) R24.xml false false R25.htm 000250 - Disclosure - Note 7 - Derivative Liability and Fair Value Measurements: Schedule of Changes in Fair Value of Plan Assets (Tables) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote7DerivativeLiabilityAndFairValueMeasurementsScheduleOfChangesInFairValueOfPlanAssetsTables Note 7 - Derivative Liability and Fair Value Measurements: Schedule of Changes in Fair Value of Plan Assets (Tables) R25.xml false false R26.htm 000260 - Disclosure - Note 10 - Warrants: Schedule of Stockholder's Equity Note Warrants Or Rights (Tables) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote10WarrantsScheduleOfStockholderSEquityNoteWarrantsOrRightsTables Note 10 - Warrants: Schedule of Stockholder's Equity Note Warrants Or Rights (Tables) R26.xml false false R27.htm 000270 - Disclosure - Note 2 - Going Concern (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote2GoingConcernDetails Note 2 - Going Concern (Details) R27.xml false false R28.htm 000280 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesScheduleOfDerivativeInstrumentsDetails Note 3 - Summary of Significant Accounting Policies: Schedule of derivative instruments (Details) R28.xml false false R29.htm 000290 - Disclosure - Note 3 - Summary of Significant Accounting Policies: Schedule Of Fair Value Of Financial Instruments (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote3SummaryOfSignificantAccountingPoliciesScheduleOfFairValueOfFinancialInstrumentsDetails Note 3 - Summary of Significant Accounting Policies: Schedule Of Fair Value Of Financial Instruments (Details) R29.xml false false R30.htm 000300 - Disclosure - Note 4 - Equipment (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote4EquipmentDetails Note 4 - Equipment (Details) R30.xml false false R31.htm 000310 - Disclosure - Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote4EquipmentScheduleOfPropertyAndEquipmentDetails Note 4 - Equipment: ScheduleOfPropertyAndEquipment (Details) R31.xml false false R32.htm 000320 - Disclosure - Note 5 - Accrued Liabilities (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote5AccruedLiabilitiesDetails Note 5 - Accrued Liabilities (Details) R32.xml false false R33.htm 000330 - Disclosure - Note 6 - Note Payable (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote6NotePayableDetails Note 6 - Note Payable (Details) R33.xml false false R34.htm 000340 - Disclosure - Note 7 - Derivative Liability and Fair Value Measurements (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote7DerivativeLiabilityAndFairValueMeasurementsDetails Note 7 - Derivative Liability and Fair Value Measurements (Details) R34.xml false false R35.htm 000350 - Disclosure - Note 7 - Derivative Liability and Fair Value Measurements: Schedule of Changes in Fair Value of Plan Assets (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote7DerivativeLiabilityAndFairValueMeasurementsScheduleOfChangesInFairValueOfPlanAssetsDetails Note 7 - Derivative Liability and Fair Value Measurements: Schedule of Changes in Fair Value of Plan Assets (Details) R35.xml false false R36.htm 000360 - Disclosure - Note 8 - Preferred Stock (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote8PreferredStockDetails Note 8 - Preferred Stock (Details) R36.xml false false R37.htm 000370 - Disclosure - Note 9 - Common Stock (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote9CommonStockDetails Note 9 - Common Stock (Details) R37.xml false false R38.htm 000380 - Disclosure - Note 10 - Warrants: Schedule of Stockholder's Equity Note Warrants Or Rights (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote10WarrantsScheduleOfStockholderSEquityNoteWarrantsOrRightsDetails Note 10 - Warrants: Schedule of Stockholder's Equity Note Warrants Or Rights (Details) R38.xml false false R39.htm 000390 - Disclosure - Note 10 - Warrants (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote10WarrantsDetails Note 10 - Warrants (Details) R39.xml false false R40.htm 000400 - Disclosure - Note 11 - Stock Options (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote11StockOptionsDetails Note 11 - Stock Options (Details) R40.xml false false R41.htm 000410 - Disclosure - Note 12- Subsequent Events (Details) Sheet http://signpathpharma.com/20130630/role/idr_DisclosureNote12SubsequentEventsDetails Note 12- Subsequent Events (Details) R41.xml false false All Reports Book All Reports Process Flow-Through: 000020 - Statement - Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2013' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 000030 - Statement - Balance Sheets Parenthetical Process Flow-Through: 000040 - Statement - Statements of Operations Process Flow-Through: 000050 - Statement - Statements of Cash Flows sppxbrl-20130630.xml sppxbrl-20130630.xsd sppxbrl-20130630_cal.xml sppxbrl-20130630_def.xml sppxbrl-20130630_lab.xml sppxbrl-20130630_pre.xml true true